These early studies confirmed the once-weekly dosing feasibility and identified the gastrointestinal side effectsprimarily nausea, vomiting, and diarrheathat would become characteristic of GLP-1 receptor agonist therapy
Petri KCC, Ingwersen SH, Flint A, Zacho J, Overgaard RV
Defects in SDH subunits lead to succinate accumulation and oncometabolite-driven pseudohypoxia and are strongly linked to hereditary paragangliomas, pheochromocytomas and certain renal cell carcinomas, underscoring the essential role of complex II in metabolic and redox homeostasis 78,79
Centrally, it crosses the bloodbrain barrier to engage GLP-1 receptors in the arcuate nucleus and brainstem, modulating POMC neurons and other appetite-regulatory circuits to reduce food intake and cravings
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
Schedule a Weight-Loss Consultation What Is Zepbound